For cancer patients, maintaining muscle is vital to health and treatment, but staying strong is complicated
Meghan McCue, Laurentian University Nearly one-third of cancer patients die from a side-effect you’ve likely…
Browsing: Featured
The Lancet Oncology: Risk of dying from cancer in some poorer districts of England over 70% higher than wealthy districts, study suggests
The risk of dying from the 10 forms of cancer with the largest death toll…
Scientists use organoid model to identify potential new pancreatic cancer treatment
A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover…
OJC 2023 Practice-Changing Papers: Part 2
The Oncology Network is delighted to share the second part of a new episode of…
OJC 2023 Practice-Changing Papers: Part 1
The Oncology Network is delighted to share the first part of a new episode of The…
Fungus-fighting protein could help overcome severe autoimmune disease and cancer
A protein in the immune system programmed to protect the body from fungal infections is…
ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
Non-Hispanic Black patients with acute myeloid leukaemia (AML) are living longer, now that new therapies are available,…
New health mapping study pinpoints cancer risk factors at local level
A new QUT-led study that maps health statistics in Australia highlights the disparities in small…
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for the treatment of relapsed or refractory mantle cell lymphoma (r/r MCL)
This content is password-protected. To view it, please enter the password below. Password:
Chefs, comedians and celebrities show their cheeky side for a new ‘rude food’ fundraising cookbook
The new ‘Rude Food’ cookbook from ‘below the belt’ cancer research organisation, ANZUP, showcases some…